The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Targeted Protein Degradation-Global Market Insights and Sales Trends 2024
Synopsis
The global Targeted Protein Degradation market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Targeted Protein Degradation in various end use industries. The expanding demands from the Hospital and Research Institute, are propelling Targeted Protein Degradation market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intravenous segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Targeted Protein Degradation market, driven by demand from China, the second largest economy with some signs of stabilising, the Targeted Protein Degradation market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Targeted Protein Degradation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Targeted Protein Degradation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Targeted Protein Degradation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Targeted Protein Degradation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Targeted Protein Degradation covered in this report include 5AM Venture Management LLC, AbbVie Inc, Almac Group, Amgen Inc., Bayer AG, Biogen Inc., C4 Therapeutics, Cosmo Bio USA and Covance Inc, etc.
The global Targeted Protein Degradation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
5AM Venture Management LLC
AbbVie Inc
Almac Group
Amgen Inc.
Bayer AG
Biogen Inc.
C4 Therapeutics
Cosmo Bio USA
Covance Inc
Eli Lilly and Company
Gilead Sciences, Inc
GlaxoSmithKline plc
Merck KGaA
Mission Therapeutics
Novartis AG
Pfizer Inc
Promega
Global Targeted Protein Degradation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Targeted Protein Degradation market, Segment by Type:
Oral
Intravenous
Others
Global Targeted Protein Degradation market, by Application
Hospital
Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Targeted Protein Degradation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Targeted Protein Degradation market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Targeted Protein Degradation in various end use industries. The expanding demands from the Hospital and Research Institute, are propelling Targeted Protein Degradation market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intravenous segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Targeted Protein Degradation market, driven by demand from China, the second largest economy with some signs of stabilising, the Targeted Protein Degradation market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Targeted Protein Degradation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Targeted Protein Degradation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Targeted Protein Degradation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Targeted Protein Degradation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Targeted Protein Degradation covered in this report include 5AM Venture Management LLC, AbbVie Inc, Almac Group, Amgen Inc., Bayer AG, Biogen Inc., C4 Therapeutics, Cosmo Bio USA and Covance Inc, etc.
The global Targeted Protein Degradation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
5AM Venture Management LLC
AbbVie Inc
Almac Group
Amgen Inc.
Bayer AG
Biogen Inc.
C4 Therapeutics
Cosmo Bio USA
Covance Inc
Eli Lilly and Company
Gilead Sciences, Inc
GlaxoSmithKline plc
Merck KGaA
Mission Therapeutics
Novartis AG
Pfizer Inc
Promega
Global Targeted Protein Degradation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Targeted Protein Degradation market, Segment by Type:
Oral
Intravenous
Others
Global Targeted Protein Degradation market, by Application
Hospital
Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Targeted Protein Degradation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Targeted Protein Degradation
1.1 Targeted Protein Degradation Market Overview
1.1.1 Targeted Protein Degradation Product Scope
1.1.2 Targeted Protein Degradation Market Status and Outlook
1.2 Global Targeted Protein Degradation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Targeted Protein Degradation Market Size by Region (2018-2029)
1.4 Global Targeted Protein Degradation Historic Market Size by Region (2018-2023)
1.5 Global Targeted Protein Degradation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Targeted Protein Degradation Market Size (2018-2029)
1.6.1 North America Targeted Protein Degradation Market Size (2018-2029)
1.6.2 Europe Targeted Protein Degradation Market Size (2018-2029)
1.6.3 Asia-Pacific Targeted Protein Degradation Market Size (2018-2029)
1.6.4 Latin America Targeted Protein Degradation Market Size (2018-2029)
1.6.5 Middle East & Africa Targeted Protein Degradation Market Size (2018-2029)
2 Targeted Protein Degradation Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Intravenous
2.1.3 Others
2.2 Global Targeted Protein Degradation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Targeted Protein Degradation Historic Market Size by Type (2018-2023)
2.2.2 Global Targeted Protein Degradation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Targeted Protein Degradation Revenue Breakdown by Type (2018-2029)
3 Targeted Protein Degradation Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Research Institute
3.2 Global Targeted Protein Degradation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Targeted Protein Degradation Historic Market Size by Application (2018-2023)
3.2.2 Global Targeted Protein Degradation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Targeted Protein Degradation Revenue Breakdown by Application (2018-2029)
4 Targeted Protein Degradation Competition Analysis by Players
4.1 Global Targeted Protein Degradation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Protein Degradation as of 2022)
4.3 Date of Key Players Enter into Targeted Protein Degradation Market
4.4 Global Top Players Targeted Protein Degradation Headquarters and Area Served
4.5 Key Players Targeted Protein Degradation Product Solution and Service
4.6 Competitive Status
4.6.1 Targeted Protein Degradation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 5AM Venture Management LLC
5.1.1 5AM Venture Management LLC Profile
5.1.2 5AM Venture Management LLC Main Business
5.1.3 5AM Venture Management LLC Targeted Protein Degradation Products, Services and Solutions
5.1.4 5AM Venture Management LLC Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.1.5 5AM Venture Management LLC Recent Developments
5.2 AbbVie Inc
5.2.1 AbbVie Inc Profile
5.2.2 AbbVie Inc Main Business
5.2.3 AbbVie Inc Targeted Protein Degradation Products, Services and Solutions
5.2.4 AbbVie Inc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.2.5 AbbVie Inc Recent Developments
5.3 Almac Group
5.3.1 Almac Group Profile
5.3.2 Almac Group Main Business
5.3.3 Almac Group Targeted Protein Degradation Products, Services and Solutions
5.3.4 Almac Group Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.3.5 Amgen Inc. Recent Developments
5.4 Amgen Inc.
5.4.1 Amgen Inc. Profile
5.4.2 Amgen Inc. Main Business
5.4.3 Amgen Inc. Targeted Protein Degradation Products, Services and Solutions
5.4.4 Amgen Inc. Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.4.5 Amgen Inc. Recent Developments
5.5 Bayer AG
5.5.1 Bayer AG Profile
5.5.2 Bayer AG Main Business
5.5.3 Bayer AG Targeted Protein Degradation Products, Services and Solutions
5.5.4 Bayer AG Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer AG Recent Developments
5.6 Biogen Inc.
5.6.1 Biogen Inc. Profile
5.6.2 Biogen Inc. Main Business
5.6.3 Biogen Inc. Targeted Protein Degradation Products, Services and Solutions
5.6.4 Biogen Inc. Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.6.5 Biogen Inc. Recent Developments
5.7 C4 Therapeutics
5.7.1 C4 Therapeutics Profile
5.7.2 C4 Therapeutics Main Business
5.7.3 C4 Therapeutics Targeted Protein Degradation Products, Services and Solutions
5.7.4 C4 Therapeutics Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.7.5 C4 Therapeutics Recent Developments
5.8 Cosmo Bio USA
5.8.1 Cosmo Bio USA Profile
5.8.2 Cosmo Bio USA Main Business
5.8.3 Cosmo Bio USA Targeted Protein Degradation Products, Services and Solutions
5.8.4 Cosmo Bio USA Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.8.5 Cosmo Bio USA Recent Developments
5.9 Covance Inc
5.9.1 Covance Inc Profile
5.9.2 Covance Inc Main Business
5.9.3 Covance Inc Targeted Protein Degradation Products, Services and Solutions
5.9.4 Covance Inc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.9.5 Covance Inc Recent Developments
5.10 Eli Lilly and Company
5.10.1 Eli Lilly and Company Profile
5.10.2 Eli Lilly and Company Main Business
5.10.3 Eli Lilly and Company Targeted Protein Degradation Products, Services and Solutions
5.10.4 Eli Lilly and Company Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.10.5 Eli Lilly and Company Recent Developments
5.11 Gilead Sciences, Inc
5.11.1 Gilead Sciences, Inc Profile
5.11.2 Gilead Sciences, Inc Main Business
5.11.3 Gilead Sciences, Inc Targeted Protein Degradation Products, Services and Solutions
5.11.4 Gilead Sciences, Inc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.11.5 Gilead Sciences, Inc Recent Developments
5.12 GlaxoSmithKline plc
5.12.1 GlaxoSmithKline plc Profile
5.12.2 GlaxoSmithKline plc Main Business
5.12.3 GlaxoSmithKline plc Targeted Protein Degradation Products, Services and Solutions
5.12.4 GlaxoSmithKline plc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.12.5 GlaxoSmithKline plc Recent Developments
5.13 Merck KGaA
5.13.1 Merck KGaA Profile
5.13.2 Merck KGaA Main Business
5.13.3 Merck KGaA Targeted Protein Degradation Products, Services and Solutions
5.13.4 Merck KGaA Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.13.5 Merck KGaA Recent Developments
5.14 Mission Therapeutics
5.14.1 Mission Therapeutics Profile
5.14.2 Mission Therapeutics Main Business
5.14.3 Mission Therapeutics Targeted Protein Degradation Products, Services and Solutions
5.14.4 Mission Therapeutics Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.14.5 Mission Therapeutics Recent Developments
5.15 Novartis AG
5.15.1 Novartis AG Profile
5.15.2 Novartis AG Main Business
5.15.3 Novartis AG Targeted Protein Degradation Products, Services and Solutions
5.15.4 Novartis AG Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.15.5 Novartis AG Recent Developments
5.16 Pfizer Inc
5.16.1 Pfizer Inc Profile
5.16.2 Pfizer Inc Main Business
5.16.3 Pfizer Inc Targeted Protein Degradation Products, Services and Solutions
5.16.4 Pfizer Inc Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.16.5 Pfizer Inc Recent Developments
5.17 Promega
5.17.1 Promega Profile
5.17.2 Promega Main Business
5.17.3 Promega Targeted Protein Degradation Products, Services and Solutions
5.17.4 Promega Targeted Protein Degradation Revenue (US$ Million) & (2018-2023)
5.17.5 Promega Recent Developments
6 North America
6.1 North America Targeted Protein Degradation Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Targeted Protein Degradation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Targeted Protein Degradation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Targeted Protein Degradation Market Dynamics
11.1 Targeted Protein Degradation Industry Trends
11.2 Targeted Protein Degradation Market Drivers
11.3 Targeted Protein Degradation Market Challenges
11.4 Targeted Protein Degradation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
